| positive regulation of transforming growth factor beta2 production |
| positive regulation of cardiac muscle myoblast proliferation |
| regulation of cardiac muscle myoblast proliferation |
| regulation of transforming growth factor beta2 production |
| positive regulation of myoblast proliferation |
| cAMP response element binding protein binding |
| response to water deprivation |
| regulation of myoblast proliferation |
| cAMP response element binding |
| intra-S DNA damage checkpoint |
| response to water |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process |
| mitochondrial outer membrane permeabilization involved in programmed cell death |
| positive regulation of transforming growth factor beta production |
| positive regulation of mitochondrial membrane permeability |
| amelogenesis |
| regulation of mitochondrial membrane permeability involved in apoptotic process |
| positive regulation of membrane permeability |
| enhancer sequence-specific DNA binding |
| regulation of transforming growth factor beta production |
| adipose tissue development |
| histone acetyltransferase activity |
| RNA polymerase II activating transcription factor binding |
| positive regulation of neuron apoptotic process |
| site of double-strand break |
| apoptotic mitochondrial changes |
| regulation of mitochondrial membrane permeability |
| outflow tract morphogenesis |
| response to osmotic stress |
| regulation of membrane permeability |
| odontogenesis of dentin-containing tooth |
| positive regulation of neuron death |
| mitotic DNA damage checkpoint |
| RNA polymerase II distal enhancer sequence-specific DNA binding |
| negative regulation of angiogenesis |
| mitotic DNA integrity checkpoint |
| negative regulation of blood vessel morphogenesis |
| fat cell differentiation |
| histone acetylation |
| negative regulation of vasculature development |
| internal peptidyl-lysine acetylation |
| odontogenesis |
| peptidyl-lysine acetylation |
| internal protein amino acid acetylation |
| negative regulation of epithelial cell proliferation |
| mitochondrial membrane organization |
| DNA damage checkpoint |
| protein acetylation |
| DNA integrity checkpoint |
| mitotic cell cycle checkpoint |
| mitochondrial outer membrane |
| protein acylation |
| cell cycle checkpoint |
| regulation of neuron apoptotic process |
| mitochondrial transport |
| connective tissue development |
| heart morphogenesis |
| positive regulation of DNA-binding transcription factor activity |
| regulation of angiogenesis |
| negative regulation of mitotic cell cycle |
| regulation of neuron death |
| RNA polymerase II regulatory region sequence-specific DNA binding |
| peptidyl-lysine modification |
| regulation of vasculature development |
| regulation of epithelial cell proliferation |
| response to acid chemical |
| histone modification |
| covalent chromatin modification |
| chromatin binding |
| regulation of DNA-binding transcription factor activity |
| mitochondrion organization |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| positive regulation of cytokine production |
| protein kinase binding |
| protein heterodimerization activity |
| heart development |
| response to inorganic substance |
| negative regulation of cell cycle |
| mitotic cell cycle process |
| regulation of mitotic cell cycle |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| DNA-binding transcription factor activity |
| negative regulation of cell population proliferation |
| mitotic cell cycle |
| regulation of cytokine production |
| positive regulation of cell death |
| chromatin organization |
| cellular response to DNA damage stimulus |
| membrane organization |
| negative regulation of transcription by RNA polymerase II |
| circulatory system development |
| peptidyl-amino acid modification |
| anatomical structure formation involved in morphogenesis |
| positive regulation of cell population proliferation |
| apoptotic process |
| negative regulation of developmental process |
| animal organ morphogenesis |
| cell cycle process |
| programmed cell death |
| regulation of anatomical structure morphogenesis |
| chromosome organization |
| cell death |
| response to abiotic stimulus |
| regulation of cell cycle |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of RNA metabolic process |
| cell cycle |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| regulation of cell population proliferation |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| regulation of cell death |
| cellular response to stress |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of molecular function |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
